Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Deloitte
QuintilesIMS
AstraZeneca
Cipla
Fuji
Citi
Teva
Johnson and Johnson

Generated: April 19, 2018

DrugPatentWatch Database Preview

MOBAN Drug Profile

« Back to Dashboard

When do Moban patents expire, and what generic alternatives are available?

Moban is a drug marketed by Endo Pharms and is included in two NDAs.

The generic ingredient in MOBAN is molindone hydrochloride. There are four drug master file entries for this compound. Additional details are available on the molindone hydrochloride profile page.
Drug patent expirations by year for MOBAN
Medical Subject Heading (MeSH) Categories for MOBAN
Synonyms for MOBAN
15622-65-8
3-Ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-4H-indol-4-one hydrochloride
3-Ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-4H-indol-4-oneHydrochloride
3-Ethyl-2-Methyl-5-(4-Morpholin-4-Iumylmethyl)-1,5,6,7-Tetrahydroindol-4-One Chloride; 3-Ethyl-6,7-Dihydro-2-Methyl-5-(Morpholinomethyl)Indol-4(5H)-One Monohydrochloride; 3-Ethyl-6,7-Dihydro-2-Methyl-5-Morpholinomethylindol-4
3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-4,5,6,7-tetrahydro-1H-indol-4-one hydrochloride
3-Ethyl-6,7-dihydro-2-methyl-5-(morpholinomethyl)-1H-indol-4(5H)-one Hydrochloride
3-Ethyl-6,7-dihydro-2-methyl-5-(morpholinomethyl)indol-4(5H)-one monohydrochloride
3-Ethyl-6,7-dihydro-2-methyl-5-morpholinomethylindol-4(5H)-one hydrochloride
4H-Indol-4-one, 3-ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-, monohydrochloride
7416-34-4 (Parent)
AC-22611
AC1Q39NF
AKOS025401596
AOB5379
API0004721
AS-13875
C16H25N2O2Cl
CAS-15622-65-8
CCG-213599
CHEBI:6966
CHEMBL1200419
CPD000499578
CS-4531
CTK6D0630
D00796
DSSTox_CID_25417
DSSTox_GSID_45417
DSSTox_RID_80866
DTXSID5045417
EN 1733 A
EN 1733A
EN-1733A
EN300-51039
EU-0100665
FT-0672453
HMS1571O11
HY-B1017
Indol-4(5H)-one, 3-ethyl-6,7-dihydro-2-methyl-5-(morpholinomethyl)-, monohydrochloride
J-009287
Lidone
Lindone
LP00665
M2252
MFCD01718304
MLS001076677
MLS001333061
MLS001333062
MLS002222311
Moban (TN)
Molindone (hydrochloride)
Molindone HCl
Molindone hydrochloride
Molindone hydrochloride (USP)
Molindone hydrochloride [USAN:USP]
Molindone hydrochloride, >=98% (HPLC), solid
Molindone hydrochloride, United States Pharmacopeia (USP) Reference Standard
MolPort-006-395-239
NC00658
NCGC00016717-01
NCGC00094027-01
NCGC00162218-05
NCGC00261350-01
SAM002548933
SCHEMBL41018
SMR000499578
SPN-810
SR-01000765437
SR-01000765437-3
Tox21_110579
Tox21_110579_1
Tox21_500665
V1985

US Patents and Regulatory Information for MOBAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms MOBAN molindone hydrochloride CAPSULE;ORAL 017111-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms MOBAN molindone hydrochloride TABLET;ORAL 017111-006 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms MOBAN molindone hydrochloride CONCENTRATE;ORAL 017938-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms MOBAN molindone hydrochloride TABLET;ORAL 017111-007 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for MOBAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo Pharms MOBAN molindone hydrochloride TABLET;ORAL 017111-004 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms MOBAN molindone hydrochloride TABLET;ORAL 017111-005 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms MOBAN molindone hydrochloride TABLET;ORAL 017111-006 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms MOBAN molindone hydrochloride CONCENTRATE;ORAL 017938-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
Mallinckrodt
Chubb
Argus Health
Daiichi Sankyo
Fish and Richardson
Deloitte
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.